Maslova · Eksperimental'naia i klinicheskaia farmakologiia 1994 · controlled animal experiment · n=?

[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress].

Cited 56 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Animal laboratory study with no human data

PubMed 7756969 · record verified 2026-08-28

What was done

Investigators studied the effects of repeated Rhodiola rosea extract administration on stress-induced cardiac damage assessed by 99mTc-pyrophosphate accumulation in an animal stress model. They simultaneously measured myocardial catecholamines, myocardial cAMP levels, and adrenal catecholamine concentrations.

What was found

The abstract reports no numerical data, baseline values, or statistical significance levels. Rhodiola rosea was reported to prevent stress-induced cardiac damage, prevent myocardial catecholamine release and elevated cAMP levels, and prevent the depletion of adrenal catecholamines during stress.

Why it matters

This study provides mechanistic evidence that the cardioprotective and antistressor effects of Rhodiola rosea are linked to the attenuation of stress-induced adrenergic activation in the myocardium.

Limits

The abstract contains no sample size, species identification, dosage, treatment duration, or quantitative metrics. As a preclinical animal experiment, findings cannot be directly applied to clinical human outcomes.

Cited by